Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET

Company Participants

Jon Serbousek – Director, President and Chief Executive Officer

Doug Rice – Chief Financial Officer

Alexa Huerta – Senior Director of Investor Relations and Finance

Conference Call Participants

Mathew Blackman – Stifel Financial Corp.

Jeffrey Cohen – Ladenburg Thalmann & Co. Inc.

Jim Sidoti – Sidoti & Company, LLC

Operator

Good morning, everyone and welcome to today's Orthofix Medical First Quarter 2022 Earnings Conference Call. My name is Candice and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call, with an opportunity for question-and-answer at the end. [Operator Instructions]. I would now like to pass the conference over to our host, Alexa Huerta, Senior Director of Investor Relations, Alexa, over to you.

Alexa Huerta

Thank you, Operator. And good morning, everyone. Welcome to the Orthofix First Quarter 2022 Earnings Call. Joining me on the call today are our President and Chief Executive Officer, Jon Serbousek, and Chief Financial Officer, Doug Rice. I'll start with the safe harbor statement and then pass it over to Jon. During this call, we will be making forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements, including any earnings guidance we provide and any statements about our plans, beliefs, strategies, expectations, goals, or objectives.

Investors are cautioned not to place undue reliance on such forward-looking statements as there is no assurance that the matter contained in such statements will occur. The forward-looking statements we will make on today's call are based on our beliefs and expectations as of today, May 6th, 2022. We do not undertake any obligation to revise or update such forward-looking statements. Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include the risk factors disclosed under the heading risk factors in our Form 10-K for the year ended December 31st, 2021, and Form 10-Q for the quarter ended March 31st, 2022, filed this morning, May, 6^th 2022, as well as additional SEC filings we make in the future.

If you need copies of these documents, please contact my office at Orthofix in Lewisville, Texas. In addition, on today's call, we will refer to various non-GAAP financial measures. We believe that in order to properly understand our short-term and long-term financial trends, investors may wish to review these matters as a supplement to the financial measures determined in accordance with U.S. GAAP. Please refer to today's press release announcing our first quarter 2022 results for reconciliations of these non-GAAP financial measures to our U.S. GAAP financial results. At this point, I will turn the call over to Jon.